If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.035 (2.10%)
Bid:
1.40
Ask:
1.75
Spread: 0.35 (25.00%)
Market Cap: £1.75m
LIT Live PriceLast checked at - London Stock Exchange

Intraday Litigation Cap. Share Chart

Market Update

19 Jul 2021 07:00

RNS Number : 6352F
Litigation Capital Management Ltd
19 July 2021
 

19 July 2021

 

Litigation Capital Management Limited

("LCM" or "the Company")

 

Market Update

 

 

Litigation Capital Management Limited (AIM:LIT), a leading international alternate asset manager of disputes financing solutions, is pleased to provide a market update for the year ended 30 June 2021 (FY21).

 

 

·

LCM's 10 year track record remains robust with 10 year portfolio ROIC as at 30 June 2021 of 153% and cumulative portfolio IRR of 78%

·

The Global Alternative Returns Fund (GAR) is currently 76% committed achieved in 15 months, versus an investment target period of 24 months. Overall capital commitment of US$115m of US$150m. The second fund is progressing well with a close targeted for Q3 of this calendar year

·

Applications increased 10%, with 572 applications received during FY21

·

Conversion into active investments was also consistent at 3%, with an increase in high profile quality investments requiring increased resource allocation. This conversion rate demonstrates LCM's discipline and consistency in applying its rigorous due diligence in investment selection

·

Whilst all other scale metrics showed an increase on the year prior, the level of commitments was down due to our due diligence and investment selection taking longer due to COVID. This increased due diligence time recognises a general slow-down in all sectors of legal services consequent upon COVID

·

Total portfolio capital commitment of $181m comprises $105m of Direct investments alongside a further $76m of Fund co-investment maintaining a diverse portfolio of investments

 

Patrick Moloney, CEO of LCM, commented: "LCM and our team have performed very well in what has been a tough and disrupted year. The GAR Fund is now over 75% committed, and we are making significant progress on the second fund with strong support from both existing and new investors. Notwithstanding some disruption to global justice systems, LCM's portfolio of disputes continues to mature.

"We are pleased to have achieved a significant resolution of an investment close to the end of the financial year which has generated strong revenue and exceptional performance metrics.

"We look forward to the coming year with optimism and an expectation that global economic conditions will be very conducive to growth.

 

Direct Investment

LCM's direct investments fall into two categories:

· Direct Balance sheet investments 100% funded by LCM; and

· Co-Investment funding alongside the Fund

LCM manages a direct investments portfolio with a capital commitment of $105m, which now comprises 30 separate investments including 8 investments in our acquisition strategy. Our Corporate Portfolios continue to achieve resolutions with consistent metrics.

Our portfolio of direct investments is progressing as anticipated, with our most recently announced resolution achieving an IRR of 121% and a ROIC of 313%.

Asset Management  

LCM has now committed 76% of the US$150m Fund across 22 projects while maintaining diversity across commercial litigation, insolvency disputes, class actions and arbitration.

All investors in Fund I have expressed a strong interest to participate in Fund II which is targeted at a size of US$300m. This demonstrates the strength of the relationships developed since launching Fund I in March 2020.

Application conversions were marginally lower at 3% as the restrictions imposed in response to the COVID pandemic continued across the globe. This expected lowering in conversion reflects LCM's rigorous due diligence adapting to market conditions particularly in the area of recovery. Despite the challenges faced and the limited client interaction, LCM added a number of high quality and high profile investments to its portfolio during the period. Notwithstanding these challenges, LCM maintained its rigorous investment selection process, ensuring the future performance of our portfolio is preserved and delivers in line with our track record.

 

Strategic Alliances

LCM's Strategic Alliances continue to generate applications and, as restrictions in the UK start to lift, we expect to see this increase as we resume business meetings and develop the investment selection process with the teams we work with.

The accompanying market update presentation is available on LCM's website:

https://www.lcmfinance.com/shareholders/investor-presentations-results/

 

 

Enquiries

 

Litigation Capital Management

c/o Alma PR 

Patrick Moloney, Chief Executive Officer

 

 

 

 

 

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

 

 

 

 

 

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

 

 

 

 

 

Alma PR

Tel: 020 3405 0205

Justine James

Susie Hudson

Kieran Breheny

Molly Gretton

LCM@almapr.co.uk

 

 

 

 

NOTES TO EDITORS

 

Litigation Capital Management (LCM) is a global provider of disputes finance. LCM provides capital and risk manager services into the disputes market including insolvency, commercial disputes, arbitral disputes, class actions and corporate portfolios. LCM operates two distinct business models: direct balance sheet investments and asset management. Under those business models, LCM pursues three investment strategies: single-case funding, corporate portfolio funding and the acquisition of claims.

LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management.

 

Current headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFFSIUEFSEIW
Date   Source Headline
15th Oct 20207:00 amRNSHolding(s) in Company
23rd Sep 20204:26 pmRNSHolding(s) in Company
22nd Sep 20207:00 amRNSFinal Results
10th Sep 20202:57 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNSNotice of Results
24th Aug 20207:00 amRNSFunding of Corporate Portfolio Transaction
18th Aug 20207:00 amRNSAppointment of Non-Executive Director
13th Aug 20207:16 amRNSDisputes Finance Facility with Global Law Firm
10th Jul 20207:04 amRNSMarket Update
6th Jul 20204:40 pmRNSSecond Price Monitoring Extn
6th Jul 20204:35 pmRNSPrice Monitoring Extension
2nd Jul 202010:42 amRNSBoard Updates
26th May 20207:00 amRNSAustralian Regulation of Litigation Funders
22nd May 20204:41 pmRNSSecond Price Monitoring Extn
22nd May 20204:36 pmRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSConclusion of Joint Venture Arrangement
3rd Apr 20207:08 amRNSManagement Update and Corporate Reorganisation
24th Mar 20207:00 amRNSFinal closure of US$150 million fund
23rd Mar 20207:41 amRNSDirector/PDMR Shareholding
17th Mar 20207:00 amRNSHalf-year Report
10th Mar 20207:00 amRNSFirst close of a new US$150 million fund
13th Feb 20207:00 amRNSNotice of Results
6th Feb 202012:07 pmRNSSecond Price Monitoring Extn
6th Feb 202012:02 pmRNSPrice Monitoring Extension
20th Dec 20198:04 amRNSCase Investment Settlement Update
16th Dec 20194:41 pmRNSSecond Price Monitoring Extn
16th Dec 20194:35 pmRNSPrice Monitoring Extension
11th Dec 201912:07 pmRNSSecond Price Monitoring Extn
11th Dec 201912:02 pmRNSPrice Monitoring Extension
10th Dec 20197:00 amRNSCapital Markets Event and Third-Party Fund Update
2nd Dec 20197:00 amRNSNotice of Dividend Currency Exchange Rate
21st Nov 20199:30 amRNSHolding(s) in Company
21st Nov 20198:25 amRNSResult of AGM
18th Nov 201912:23 pmRNS2019 Annual Report & Accounts
12th Nov 201912:07 pmRNSSecond Price Monitoring Extn
12th Nov 201912:02 pmRNSPrice Monitoring Extension
6th Nov 20197:00 amRNSAppointment of Joint Broker
1st Nov 201911:23 amRNSIncentive Awards
16th Oct 20198:00 amRNSNotice of Annual General Meeting
30th Sep 201912:00 pmRNSHolding(s) in Company
30th Sep 201912:00 pmRNSHolding(s) in Company
13th Sep 20193:01 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSFinal Results
2nd Sep 20197:30 amRNSNotice of Results
17th Jul 201910:42 amRNSHolding(s) in Company
28th Jun 201911:44 amRNSConditional Settlement of Litigation Project
13th Jun 20197:00 amRNSFunding of Corporate Portfolio Transaction
3rd Jun 20198:59 amRNSNotice of Dividend Currency Exchange Rate
28th May 20197:42 amRNSCourt Approval Settlement and Pipeline Update
8th Apr 201910:14 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.